A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats

作者：Xu Yang; Peng Zhangxiao; Ji Weidan; Li Xiang; Lin Xuejing; Qian Liqiang; Li Xiaoya; Chai Xiaoyun; Wu Qiuye; Gao Quangen; Su Changqing^*

来源：Biomed Research International, 2015, 2015: 203978.

DOI：10.1155/2015/203978

Activation of hepatic stellate cells (HSCs) is a critical event in process of hepatic fibrogenesis and cirrhosis. Matrine, the active ingredient of Sophora, had been used for clinical treatment of acute/chronic liver disease. However, its potency was low. We prepared a high potency and low toxicity matrine derivate, WM130 (C(30)N4H(40)SO(5)F), which exhibited better pharmacological activities on antihepatic fibrosis. This study demonstrated that WM130 results in a decreased proliferative activity of HSC-T6 cells, with the half inhibitory concentration (IC50) of 68 mu M. WM130 can inhibit the migration and induce apoptosis in HSC-T6 cells at both concentrations of 68 mu M (IC50) and 34 mu M (half IC50). The expression of alpha-SMA, Collagen I, Collagen III, and TGF-beta 1 could be downregulated, and the protein phosphorylation levels of EGFR, AKT, ERK, Smad, and Raf (p-EGFR, p-AKT, p-ERK, p-Smad, and p-Raf) were also decreased by WM130. On the DMN-induced rat liver fibrosis model, WM130 can effectively reduce the TGF-beta 1, AKT, alpha-SMA, and p-ERK levels, decrease the extracellular matrix (ECM) formation, and inhibit rat liver fibrosis progression. In conclusion, this study demonstrated that WM130 can significantly inhibit the activation of HSC-T6 cells and block the rat liver fibrosis progression by inducing apoptosis, suppressing the deposition of ECM, and inhibiting TGF-beta/Smad and Ras/ERK pathways.

• 出版日期2015
• 单位中国人民解放军第二军医大学